Posted in | News | Biosensors

Innovation Award for Fujitsu PalmSecure Palm Vein Authentication Solution

The palm vein authentication system, PalmSecure from Fujitsu has received the 2010 North American technology innovation award from Frost & Sullivan, based on the market analysis of the biometrics-enabled healthcare identity management domain.

The mostly price-based biometrics market includes end users who are opting for low-priced options to multiple-security layers, despite their susceptibility to spoofing and circumvention. This situation can be remedied by biometric companies through innovation for bridging the security-price gap.

The Common Criteria committee that is part of the Information Technology Security Evaluation Assurance Level 2’s International Common Criteria, has certified the PalmSecure technology from Fujitsu, the first vascular authentication system to receive this certification.

While researching the human anatomy’s various components for error-free biometric verification and identification, the palm's vein pattern was found to be the most complex and distinctive part.

It is possible to easily integrate the PalmSecure technology into products for time and attendance, logical and physical access control systems. The technology is likely to be successful for such applications, since it is not affected by normal quantity of grime and dirt on the palm, which normally increases the error rates while using customary fingerprint scanners.

The palm vein technology works by utilizing a high-tech sensor for extracting characteristics of the vein as a high-definition image. The image is able to capture deoxygenated hemoglobin that runs through the veins of the subject. This technology is distinctive in that the blood has to flow through the veins so that the identity of the subject can be verified or authenticated.

Fingerprint systems have large FRR and FRR of 3% and 2%, respectively. On the other hand, the more dependable iris-scan technology has FRR in the 0.99–0.2% range and FAR in the 0.0001–0.94% range. The latter expensive technology is however is used for niche applications only.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.